Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for …

2 days ago · Illumina remains an open, accessible, and enabling next-generation sequencing (NGS) platform, and will work closely with customers to provide continuity of products, services, and support …

2 days ago · --Illumina, Inc. today announced that it has completed its acquisition of SomaLogic, a leader in data-driven proteomics technology. "Welcoming the SomaLogic team to Illumina is an …

Jan 21, 2026 · Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function.

We are Illumina We are a global genomics and human health leader innovating the future of precision health. We develop DNA sequencing and array-based life sciences technologies to enable …

2 days ago · Illumina is the world leader in gene sequencing technology – the ability to read and record DNA. Now, the billion-dollar company is buying SomaLogic to focus on protein.

Illumina offers a broad range of sequencing and microarray products for diverse genomic analysis applications.

3 days ago · Shares of Illumina, Inc. (NASDAQ:ILMN - Get Free Report) have been assigned a consensus recommendation of "Hold" from the twenty ratings firms that are currently covering the …

We would like to show you a description here but the site won’t allow us.